REG01: Noninvasive Monitoring of Cerebral Blood Flow Autoregulation in Patients With Traumatic Brain Injury (TBI)

Sponsor
Advanced Brain Monitoring, Inc. (Industry)
Overall Status
Withdrawn
CT.gov ID
NCT01605838
Collaborator
University of Southern California (Other)
0
1
21
0

Study Details

Study Description

Brief Summary

BACKGROUND: The brain is very sensitive to both excessive and insufficient flow of blood. Cerebral blood flow (CBF) is normally auto-regulated by the blood vessels in the brain, but this protective mechanism is often disturbed after a traumatic brain injury (TBI). Impairment or loss of the CBF autoregulation makes the brain vulnerable to oscillations of either arterial blood pressure (ABP) or intracranial pressure (ICP). The ideal management of TBI patients, therefore, involves continuous measurement and management of the cerebral perfusion pressure (CPP = ABP - ICP) but the measurement of CPP is currently possible only with specialized equipment and expertise that is not available in all institutions. The investigators have converted a no-longer used system that continuously monitors CBF autoregulation using rheoencephalography (REG) technology into a modern, small, battery-powered, low-cost monitor (aka BM-1) that acquires the REG signals using only noninvasive electrodes placed on the skin/scalp. REG data can then be used to calculate the optimal CPP to maintain in each individual patient. BM-1 is also capable of monitoring electroencephalography (EEG) and impedance plethysmography (IPG), which can, respectively, be used to measure brain electrical activity and changes in peripheral blood flow caused by blood pressure changes.

OBJECTIVES: The primary objectives are to (Obj. 1) demonstrate that REG acquired noninvasively is equal to the well-established but invasive method using intracranial pressure (ICP) monitoring, (Obj. 2) retrospectively test the idea that TBI patients have a less favorable outcome if their CPP were found less optimal using the REG data, and (Obj. 3) determine if noninvasive IPG or the PPG finger sensor monitoring (used to measure heart rate in doctor's offices) can replace the invasive monitoring of arterial blood pressure (ABP).

METHODOLOGY: This is an observational study with retrospective data analysis. 20 adult patients (18-65 yrs) with acute TBI, who meet the inclusion/exclusion criteria, will be enrolled on a first-come-first-enroll basis. The enrolled patients will have the REG, EEG and IPG signals monitored for the duration of ICU stay or 15 days, whichever is shorter. Standard neurological assessment will be made at the patient's discharge from the ICU and at 3 months after injury. The study is expected to end June 2013.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    0 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Pilot (Feasibility) Study of New Portable Monitor for Continuous Assessment of Cerebral Blood Flow (CBF) Autoregulation in Patients With Moderate to Severe Traumatic Brain Injury (TBI)
    Study Start Date :
    Aug 1, 2012
    Anticipated Primary Completion Date :
    Jun 1, 2013
    Actual Study Completion Date :
    May 1, 2014

    Outcome Measures

    Primary Outcome Measures

    1. Extended Glasgow Outcome Scale (GOSE) [3 months post-injury]

    Secondary Outcome Measures

    1. Neurobehavioral Symptom Inventory (NSI) [3 months post-injury]

    2. Rappaport Disability Rating Scale (DSR) [At discharge from intensive care unit; on average, 10 days post-injury]

      Note regarding the time frame: based on the USC patient database for 2010 and 2011, patients may be discharged from the ICU anywhere between 4 days to 4 weeks; 50% of them will spend 10 +/- 3 days in the ICU.

    3. Katz Index of Independence in Activities of Daily Living (KI-ADL) [3 months post-injury]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Clinical diagnosis of acute moderate or severe TBI

    • Hospitalization within 12 hours from the injury

    • Intraarterial catheterization and intracranial pressure (ICP) monitoring instantiated within 72 hours from the injury

    Exclusion Criteria:
    • Earlier head injuries, stroke, space-occupying intracranial lesions, meningitis, or cerebral vasculopathies

    • Concomitant severe injuries of the chest, abdomen, pelvis, extremities or spine

    • Concurrent terminal illness with a life expectancy of less than 6 months

    • Unlikely to survive the next 48 hours after enrollment

    • Implanted cardiac pacemaker, cardiac converter/defibrillator, or other electrical stimulator

    • Pregnancy

    • Patient is a prisoner or on a probation

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 LA County + USC Medical Center Los Angeles California United States 90033

    Sponsors and Collaborators

    • Advanced Brain Monitoring, Inc.
    • University of Southern California

    Investigators

    • Principal Investigator: Djordje Popovic, MD, Advanced Brain Monitoring, Inc.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Advanced Brain Monitoring, Inc.
    ClinicalTrials.gov Identifier:
    NCT01605838
    Other Study ID Numbers:
    • ABM-TBI-0001
    • W81XWH - 10 - C - 0061
    First Posted:
    May 25, 2012
    Last Update Posted:
    Jan 14, 2015
    Last Verified:
    Jan 1, 2015
    Keywords provided by Advanced Brain Monitoring, Inc.
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 14, 2015